// App-Quantinova.ai

558 : Reverse-phase protein microarray (RPPA) analysis of PD-L1 and growth factor receptor signal transduction pathways in hormone receptor (HR)-positive primary breast cancer tissue and correlation with relapse.

Researchers

Presenter

  • Suhail M. Ali

Principal Investigators

  • Joseph J. Drabick

  • Meghan P. Riley

  • Kim Leitzel

  • Eric Marks

  • Luis Costa

  • Issam Makhoul

  • Harold A. Harvey

  • Cristina I. Truica

  • Leah Cream

  • J. Stanley Smith

  • Rena Kass

  • Kristine Widders

  • Monali K. Vasekar

  • Glenn D. Hoke

  • Nicholas N Hoke

  • Corinne Ramos

  • James Cooper

  • Allan Lipton

Medical Centers

  • Penn State Hershey Medical Center, Hershey, PA

  • Penn State Milton S. Hershey Medical Center, Palmyra, PA

  • Oncology Division, Hospital de Santa Maria - Centro Hospitalar Lisboa Norte and Instituto de Medicina Molecular, Lisbon, Portugal

  • University of Arkansas for Medical Sciences, Little Rock, AR

  • Penn State Health Milton S. Hershey Medical Center, Hershey, PA

  • Pennsylvania State Hershey Cancer Institute, Hershey, PA

  • Penn State Hershey Medical Center, Hershey, PA

  • Penn State College of Medicine, Hershey, PA

  • Theranostics Health, Inc., Rockville, MD

Locations

  • United States

  • Portugal

Companies

  • Theranostics Health,

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Mitogen-activated protein kinase

  • Nucleoside diphosphate kinase A

  • Programmed death-ligand 1

  • Epidermal growth factor receptor

  • Erb-B2 Receptor Tyrosine Kinase 3

  • Human epidermal growth factor receptor 2

  • Janus kinase

  • Serine/threonine-protein kinase mTOR

  • Hormone receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved